v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total net revenues $ 84,084 $ 69,387 $ 157,221 $ 137,909
Cost of goods sold $ 26,904 $ 24,067 $ 51,144 $ 45,934
Cost, Product and Service [Extensible Enumeration] Product revenue, net Product revenue, net Product revenue, net Product revenue, net
Gross profit $ 57,180 $ 45,320 $ 106,077 $ 91,975
Operating expenses:        
Selling, general and administrative 57,052 56,675 109,033 113,315
Research and development 1,892 1,837 4,132 4,049
Revaluation of contingent royalty obligation payable to Evolus Founders 1,250 (3,914) 1,236 (1,763)
Depreciation and amortization 1,529 932 3,067 1,756
Total operating expenses 61,723 55,530 117,468 117,357
Loss from operations (4,543) (10,210) (11,391) (25,382)
Other income (expense):        
Interest income 296 479 581 1,189
Interest expense (4,172) (7,207) (8,147) (11,622)
Other income (expense), net 213 (151) 333 (94)
Loss before income taxes (8,206) (17,089) (18,624) (35,909)
Income tax benefit (expense) 154 (53) (102) (125)
Net loss (8,052) (17,142) (18,726) (36,034)
Other comprehensive income (loss), net of tax:        
Currency translation adjustment (251) 240 (373) 306
Comprehensive loss $ (8,303) $ (16,902) $ (19,099) $ (35,728)
Net loss per share, basic (in dollars per share) $ (0.12) $ (0.27) $ (0.29) $ (0.56)
Net loss per share, diluted (in dollars per share) $ (0.12) $ (0.27) $ (0.29) $ (0.56)
Weighted-average shares outstanding used to compute basic net loss per share (in shares) 65,929,112 64,539,291 65,559,929 64,120,287
Weighted-average shares outstanding used to compute diluted net loss per share (in shares) 65,929,112 64,539,291 65,559,929 64,120,287
Product revenue, net        
Revenue:        
Total net revenues $ 83,350 $ 68,699 $ 156,097 $ 136,773
Service revenue        
Revenue:        
Total net revenues $ 734 $ 688 $ 1,124 $ 1,136